CSIR-IIIM Strengthens Global Drug Discovery Efforts with Prof. Serge Mignani
CSIR-IIIM hosts Prof Serge Mignani to boost drug discovery research

Image: Asianet Newsable
The CSIR-Indian Institute of Integrative Medicine in Jammu hosted Prof. Serge Mignani, a prominent medicinal chemist, to enhance international collaborations in drug discovery. The discussions focused on developing new therapies for tuberculosis and other diseases, emphasizing the importance of partnerships between academia and industry.
- 01Prof. Serge Mignani is a former Head of Medicinal Chemistry at Sanofi and is recognized for his contributions to pharmaceutical research.
- 02The collaborative research initiatives discussed include anti-tuberculosis drug discovery, oncology, and inflammation.
- 03Zabeer Ahmed, Director of CSIR-IIIM, highlighted the role of international collaborations in advancing healthcare solutions.
- 04Prof. Mignani shared insights on modern drug discovery and the significance of industry-academia partnerships.
- 05Both parties expressed optimism about future collaborations and advancements in infectious disease research.
Advertisement
In-Article Ad
The CSIR-Indian Institute of Integrative Medicine (CSIR-IIIM) in Jammu recently hosted Prof. Serge Mignani, a distinguished scientist in medicinal chemistry, to foster international collaborations in drug discovery. During the meeting, Prof. Mignani engaged with CSIR-IIIM Director Zabeer Ahmed and the research team to discuss ongoing projects targeting tuberculosis, oncology, and inflammation. Ahmed emphasized the critical role of global scientific partnerships in accelerating innovative healthcare solutions. Prof. Mignani, who is associated with the Drug Discovery Division at CSIR-IIIM, shared valuable insights into modern drug discovery techniques and the importance of collaborative research between academia and industry. He praised the research capabilities at CSIR-IIIM and encouraged young researchers to pursue interdisciplinary studies. The meeting concluded with both sides optimistic about future collaborations, which are expected to enhance CSIR-IIIM's international research engagement and contribute significantly to therapeutic development in infectious diseases.
Advertisement
In-Article Ad
This collaboration may lead to the development of new therapeutic agents, improving healthcare solutions for infectious diseases.
Advertisement
In-Article Ad
Reader Poll
How important is international collaboration in drug discovery?
Connecting to poll...
Read the original article
Visit the source for the complete story.




